1 |
Dial S, Alrasadi K. et al., Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitor: cohort and case-control studies. CMAJ 2004; 171:33-8.
DOI
ScienceOn
|
2 |
Musher DM, Aslam S, Logan N et al., Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005; 40:1586-90.
DOI
ScienceOn
|
3 |
Loo VG, Poirier L, Miller MA, et al., A predominantly clonal multi-institutional outbreak of Clostridium difficile associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9.
DOI
|
4 |
Maroo S, Lamont JT. Recurrent Clostridium difficile. Gastroenterology 2006; 130:1311-16.
DOI
ScienceOn
|
5 |
Chang VT, Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 2000; 31(3):717-22.
DOI
ScienceOn
|
6 |
Pepin J, Saheb N, Coulombe MA, et al., Emergence of fluoroquinlones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254-60.
DOI
ScienceOn
|
7 |
Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004; 38: 646-8.
DOI
ScienceOn
|
8 |
McFarland LV, Clarridge JE, Beneda HW, Rauqi GJ. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a veteran's administration health care system. Clin Infect Dis 2007; 45:114151.
|
9 |
McCuster ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostrdium difficile-associated diarrhea. Emerging infectious Diseases 2003; 9(6):730-3.
DOI
|
10 |
Bricker E, Gag R, Nelson R, et al., Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev CD004610, 2005.
|
11 |
Gerding DN, Muto CA, Owens RC. Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008; 46:S32-42.
DOI
|
12 |
Bartlett JG. Clinical practices: Antibiotic associated diarrhea. N Engl J Med 2002; 346(5):334-9.
DOI
ScienceOn
|
13 |
Gerding DN, Muto CA, Owens RC. Jr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008; 46:S43-9.
DOI
|
14 |
Cleary RK, Grossmann R, Fernandez FB, et al., Metronodazole may inhibit intestinal colonization with Clostridium difficile. Dis Colon Rectum 1998; 41:464-7.
DOI
ScienceOn
|
15 |
Kyne L, Hamel MB, Polavarm R, Kelly CP. Health care costs and mortality associated diarrhea with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
DOI
ScienceOn
|
16 |
Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonal LC, Fraser VJ. Clostridium difficile associated disease in a setting of Endemicity: identification of novel risk factors. Clin Infect Dis 2007; 45:1543-1549.
DOI
ScienceOn
|
17 |
Owens RC. Jr., Donskey CJ, Gaynes RP, Loo VJ, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008; 46:S19-31.
DOI
|
18 |
Kelly CP, Pothoulakis C, Lamont JT. Clostridium difficile colitis. N Engl J Med 1994; 330(4):257-62.
DOI
ScienceOn
|
19 |
Elliot B, Chang BJ, Golledge CL, Riley TV. Clostridium difficile-associated diarrhea. Internal Medicine Journal 2007; 37:561-568.
DOI
ScienceOn
|
20 |
Rice LB. The Maxwell Finland lecture: for the durationrational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile. Clin Infect Dis 2008; 46:491-6.
DOI
ScienceOn
|